Exchange: NASDAQ·Updated 03:00 PM EST
SVA logo

SVA Sinovac Biotech, Ltd.

$6.47
$0.02
(0.31%)
Today
EarningsApr 29
Mkt Cap$460.27M

About SVA

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
50

Neutral Sentiment

How do you feel about SVA?

Advertisement|Remove ads.